Glenmede Trust’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.78M | Sell |
3,368
-1,144
| -25% | -$528K | 0.01% | 612 |
|
|
2026
Q1 | $2.17M | Sell |
4,512
-420
| -9% | -$215K | 0.01% | 561 |
|
|
2025
Q4 | $2.77M | Buy |
+4,932
| New | +$2.8M | 0.01% | 519 |
|
|
2025
Q1 | $13.2M | Buy |
43,222
+269
| +0.6% | +$90.5K | 0.07% | 284 |
|
|
2024
Q4 | $14.3M | Buy |
42,953
+22,708
| +112% | +$7.7M | 0.07% | 284 |
|
|
2024
Q3 | $6.76M | Sell |
20,245
-56,046
| -73% | -$21.3M | 0.03% | 409 |
|
|
2024
Q2 | $31.4M | Buy |
76,291
+27,655
| +57% | +$11M | 0.16% | 125 |
|
|
2024
Q1 | $19.7M | Sell |
48,636
-14,079
| -22% | -$4.95M | 0.1% | 209 |
|
|
2023
Q4 | $19.2M | Sell |
62,715
-474
| -0.8% | -$128K | 0.1% | 202 |
|
|
2023
Q3 | $15.3M | Sell |
63,189
-29,944
| -32% | -$7.66M | 0.09% | 236 |
|
|
2023
Q2 | $17.8M | Buy |
93,133
+172
| +0.2% | +$35.7K | 0.1% | 213 |
|
|
2023
Q1 | $17.5M | Sell |
92,961
-735
| -0.8% | -$152K | 0.1% | 217 |
|
|
2022
Q4 | $19.9M | Sell |
93,696
-13,125
| -12% | -$2.62M | 0.12% | 190 |
|
|
2022
Q3 | $16.8M | Sell |
106,821
-12,424
| -10% | -$1.98M | 0.11% | 210 |
|
|
2022
Q2 | $17.8M | Buy |
119,245
+113,707
| +2,053% | +$16.5M | 0.1% | 221 |
|
|
2022
Q1 | $905K | Sell |
5,538
-7,317
| -57% | -$1.21M | ﹤0.01% | 744 |
|
|
2021
Q4 | $2.8M | Buy |
12,855
+327
| +3% | +$68.5K | 0.01% | 507 |
|
|
2021
Q3 | $2.37M | Buy |
12,528
+18
| +0.1% | +$3.28K | 0.01% | 520 |
|
|
2021
Q2 | $2.21M | Buy |
12,510
+228
| +2% | +$39.4K | 0.01% | 522 |
|
|
2021
Q1 | $2.01M | Sell |
12,282
-925
| -7% | -$141K | 0.01% | 524 |
|
|
2020
Q4 | $1.84M | Buy |
13,207
+2,770
| +27% | +$349K | 0.01% | 534 |
|
|
2020
Q3 | $1.17M | Sell |
10,437
-2,395
| -19% | -$277K | 0.01% | 587 |
|
|
2020
Q2 | $1.19M | Sell |
12,832
-34,616
| -73% | -$2.95M | 0.01% | 573 |
|
|
2020
Q1 | $3.99M | Hold |
47,448
| – | – | 0.02% | 491 |
|
|
2019
Q4 | $3.99M | Sell |
47,448
-1,318
| -3% | -$102K | 0.02% | 491 |
|
|
2019
Q3 | $4.1M | Buy |
48,766
+107
| +0.2% | +$8.09K | 0.02% | 493 |
|
|
2019
Q2 | $3.18M | Buy |
48,659
+86
| +0.2% | +$4.96K | 0.01% | 558 |
|
|
2019
Q1 | $2.86M | Buy |
48,573
+3,120
| +7% | +$186K | 0.01% | 583 |
|
|
2018
Q4 | $2.4M | Buy |
45,453
+30,193
| +198% | +$1.66M | 0.01% | 591 |
|
|
2018
Q3 | $914K | Buy |
+15,260
| New | +$835K | ﹤0.01% | 765 |
|
Other funds holding MEDP
WA
Glenmede Trust's MEDP Position: Q2 2026 in Review
Glenmede Trust reduced its Medpace (MEDP) stake by 25% in Q2 2026, selling an estimated $528K and leaving 3,368 shares worth $1.78M. The position accounts for 0.01% of the portfolio, ranked #612.
Glenmede Trust first reported a position in MEDP in Q3 2018 and has held it in 30 quarters since. The position peaked at $31.4M in Q2 2024. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Glenmede Trust held 3,368 shares of Medpace worth $1.78M as of Q2 2026.
- Glenmede Trust sold 1,144 Medpace shares in Q2 2026, an estimated $528K.
- Medpace made up 0.01% of Glenmede Trust's portfolio in Q2 2026, its #612 holding.
- Glenmede Trust first reported a position in Medpace in Q3 2018 and has held it in 30 quarters since.
- Glenmede Trust's Medpace position peaked at $31.4M in Q2 2024.
- 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.